Isorhamnetin derivatives and piscidic acid for hypercholesterolemia: cholesterol permeability, HMG-CoA reductase inhibition, and docking studies

Detalhes bibliográficos
Autor(a) principal: RESSAISSI, Asma
Data de Publicação: 2017
Outros Autores: ATTIA, Nebil, Falé, Pedro Luís, Pacheco, Rita, Victor, Bruno L., Machuqueiro, Miguel, Serralheiro, Maria Luísa M.
Tipo de documento: Artigo
Idioma: eng
Título da fonte: Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
Texto Completo: http://hdl.handle.net/10400.21/8143
Resumo: Bioactive compounds, such as isorhamnetin and piscidic acid, were obtained from decoctions of cladodes (stem pads from Opuntia ficus-indica). The effect of these phenolic compounds, in a fiber-free extract, were evaluated as inhibitors of cholesterol permeation through a Caco-2 cell monolayer and as 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitor. A reduction of 38% in cholesterol permeation through the Caco-2 cell monolayer was obtained, and the phenolic compounds all permeated between 6 and 9%. A mixture of these compounds showed an IC50 of 20.3 mu g/mL as an enzyme inhibitor, whereas piscidic acid alone showed an IC50 of 149.6 mu g/mL; this was slightly outperformed by the isorhamnetin derivatives. Docking studies confirmed that both piscidic acid and isorhamnetin derivatives, present in the decoction, could adequately bind to the enzyme active site. These results reveal that O. ficus-indica, and cladodes derived there from, is a promising plant for use in the development of new functional foods and pharmaceutical products.
id RCAP_cf39f7f21fd06bf8c49fe59f1170130f
oai_identifier_str oai:repositorio.ipl.pt:10400.21/8143
network_acronym_str RCAP
network_name_str Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
repository_id_str 7160
spelling Isorhamnetin derivatives and piscidic acid for hypercholesterolemia: cholesterol permeability, HMG-CoA reductase inhibition, and docking studiesIsorhamnetin derivativesCholesterol permeabilityCell linesHMG-CoA reductaseDocking studiesPiscidic acidBioactive compounds, such as isorhamnetin and piscidic acid, were obtained from decoctions of cladodes (stem pads from Opuntia ficus-indica). The effect of these phenolic compounds, in a fiber-free extract, were evaluated as inhibitors of cholesterol permeation through a Caco-2 cell monolayer and as 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitor. A reduction of 38% in cholesterol permeation through the Caco-2 cell monolayer was obtained, and the phenolic compounds all permeated between 6 and 9%. A mixture of these compounds showed an IC50 of 20.3 mu g/mL as an enzyme inhibitor, whereas piscidic acid alone showed an IC50 of 149.6 mu g/mL; this was slightly outperformed by the isorhamnetin derivatives. Docking studies confirmed that both piscidic acid and isorhamnetin derivatives, present in the decoction, could adequately bind to the enzyme active site. These results reveal that O. ficus-indica, and cladodes derived there from, is a promising plant for use in the development of new functional foods and pharmaceutical products.Springer Publishing CompanyRCIPLRESSAISSI, AsmaATTIA, NebilFalé, Pedro LuísPacheco, RitaVictor, Bruno L.Machuqueiro, MiguelSerralheiro, Maria Luísa M.2018-02-27T14:31:36Z2017-112017-11-01T00:00:00Zinfo:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/articleapplication/pdfhttp://hdl.handle.net/10400.21/8143engRESSAISSI, Asma; [et al] – Isorhamnetin derivatives and piscidic acid for hypercholesterolemia: cholesterol permeability, HMG-CoA reductase inhibition, and docking studies. Archives of Pharmacal Research. ISSN 0253-6269. Vol. 40, N.º 11, (2017), pp. 1278-1286.0253-626910.1007/s12272-017-0959-1metadata only accessinfo:eu-repo/semantics/openAccessreponame:Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)instname:Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informaçãoinstacron:RCAAP2023-08-03T09:55:08Zoai:repositorio.ipl.pt:10400.21/8143Portal AgregadorONGhttps://www.rcaap.pt/oai/openaireopendoar:71602024-03-19T20:16:57.464532Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) - Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informaçãofalse
dc.title.none.fl_str_mv Isorhamnetin derivatives and piscidic acid for hypercholesterolemia: cholesterol permeability, HMG-CoA reductase inhibition, and docking studies
title Isorhamnetin derivatives and piscidic acid for hypercholesterolemia: cholesterol permeability, HMG-CoA reductase inhibition, and docking studies
spellingShingle Isorhamnetin derivatives and piscidic acid for hypercholesterolemia: cholesterol permeability, HMG-CoA reductase inhibition, and docking studies
RESSAISSI, Asma
Isorhamnetin derivatives
Cholesterol permeability
Cell lines
HMG-CoA reductase
Docking studies
Piscidic acid
title_short Isorhamnetin derivatives and piscidic acid for hypercholesterolemia: cholesterol permeability, HMG-CoA reductase inhibition, and docking studies
title_full Isorhamnetin derivatives and piscidic acid for hypercholesterolemia: cholesterol permeability, HMG-CoA reductase inhibition, and docking studies
title_fullStr Isorhamnetin derivatives and piscidic acid for hypercholesterolemia: cholesterol permeability, HMG-CoA reductase inhibition, and docking studies
title_full_unstemmed Isorhamnetin derivatives and piscidic acid for hypercholesterolemia: cholesterol permeability, HMG-CoA reductase inhibition, and docking studies
title_sort Isorhamnetin derivatives and piscidic acid for hypercholesterolemia: cholesterol permeability, HMG-CoA reductase inhibition, and docking studies
author RESSAISSI, Asma
author_facet RESSAISSI, Asma
ATTIA, Nebil
Falé, Pedro Luís
Pacheco, Rita
Victor, Bruno L.
Machuqueiro, Miguel
Serralheiro, Maria Luísa M.
author_role author
author2 ATTIA, Nebil
Falé, Pedro Luís
Pacheco, Rita
Victor, Bruno L.
Machuqueiro, Miguel
Serralheiro, Maria Luísa M.
author2_role author
author
author
author
author
author
dc.contributor.none.fl_str_mv RCIPL
dc.contributor.author.fl_str_mv RESSAISSI, Asma
ATTIA, Nebil
Falé, Pedro Luís
Pacheco, Rita
Victor, Bruno L.
Machuqueiro, Miguel
Serralheiro, Maria Luísa M.
dc.subject.por.fl_str_mv Isorhamnetin derivatives
Cholesterol permeability
Cell lines
HMG-CoA reductase
Docking studies
Piscidic acid
topic Isorhamnetin derivatives
Cholesterol permeability
Cell lines
HMG-CoA reductase
Docking studies
Piscidic acid
description Bioactive compounds, such as isorhamnetin and piscidic acid, were obtained from decoctions of cladodes (stem pads from Opuntia ficus-indica). The effect of these phenolic compounds, in a fiber-free extract, were evaluated as inhibitors of cholesterol permeation through a Caco-2 cell monolayer and as 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitor. A reduction of 38% in cholesterol permeation through the Caco-2 cell monolayer was obtained, and the phenolic compounds all permeated between 6 and 9%. A mixture of these compounds showed an IC50 of 20.3 mu g/mL as an enzyme inhibitor, whereas piscidic acid alone showed an IC50 of 149.6 mu g/mL; this was slightly outperformed by the isorhamnetin derivatives. Docking studies confirmed that both piscidic acid and isorhamnetin derivatives, present in the decoction, could adequately bind to the enzyme active site. These results reveal that O. ficus-indica, and cladodes derived there from, is a promising plant for use in the development of new functional foods and pharmaceutical products.
publishDate 2017
dc.date.none.fl_str_mv 2017-11
2017-11-01T00:00:00Z
2018-02-27T14:31:36Z
dc.type.status.fl_str_mv info:eu-repo/semantics/publishedVersion
dc.type.driver.fl_str_mv info:eu-repo/semantics/article
format article
status_str publishedVersion
dc.identifier.uri.fl_str_mv http://hdl.handle.net/10400.21/8143
url http://hdl.handle.net/10400.21/8143
dc.language.iso.fl_str_mv eng
language eng
dc.relation.none.fl_str_mv RESSAISSI, Asma; [et al] – Isorhamnetin derivatives and piscidic acid for hypercholesterolemia: cholesterol permeability, HMG-CoA reductase inhibition, and docking studies. Archives of Pharmacal Research. ISSN 0253-6269. Vol. 40, N.º 11, (2017), pp. 1278-1286.
0253-6269
10.1007/s12272-017-0959-1
dc.rights.driver.fl_str_mv metadata only access
info:eu-repo/semantics/openAccess
rights_invalid_str_mv metadata only access
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv application/pdf
dc.publisher.none.fl_str_mv Springer Publishing Company
publisher.none.fl_str_mv Springer Publishing Company
dc.source.none.fl_str_mv reponame:Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
instname:Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação
instacron:RCAAP
instname_str Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação
instacron_str RCAAP
institution RCAAP
reponame_str Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
collection Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
repository.name.fl_str_mv Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) - Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação
repository.mail.fl_str_mv
_version_ 1799133430675406848